Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 18 December 2007. doi:10.1136/ard.2007.077537
Annals of the Rheumatic Diseases 2008;67:1461-1467
Copyright © 2008 BMJ Publishing Group Ltd & European League Against Rheumatism.

BASIC AND TRANSLATIONAL RESEARCH

Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor {alpha} (WSX-1)

N Sugiyama1, H Nakashima1,2, T Yoshimura3,4, A Sadanaga1, S Shimizu1, K Masutani5, T Igawa1, M Akahoshi1, K Miyake1,2, A Takeda3,4, A Yoshimura4, S Hamano6, H Yoshida7

1 Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
2 Division of Nephrology and Rheumatology, Department of Internal Medicine, Fukuoka University, School of Medicine, Fukuoka, Japan
3 Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
4 Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan
5 Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
6 Department of Parasitology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
7 Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga, Japan

H Nakashima, Division of Nephrology and Rheumatology, Department of Internal Medicine, Fukuoka University, School of Medicine, 7–45–1 Nanakuma, Jonann-ku, Fukuoka 814–0180, Japan; hnakashi{at}fukuoka-u.ac.jp and H Yoshida, Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga, 849–8501, Japan; yoshidah{at}med.saga-u.ac.jp

Objective: In the present work, we investigate the role of interleukin (IL)27/IL27 receptor {alpha} (R{alpha}) (WSX-1) in the development of autoimmune disorders in the MRL/lpr mouse, which is considered as an experimental model of systemic lupus erythaematosus (SLE) in humans.

Methods: We generated two strains of WSX-1 transgenic mice in the MRL/lpr background with different expression levels of WSX-1, and investigated the effect of WSX-1 overexpression on survival, glomerulonephritis and immunological properties.

Results: In comparison with wild type (WT) MRL/lpr and transgenic (Tg) low (TgL) mice, Tg high (TgH) mice exhibited a prolonged lifespan and no apparent development of autoimmune nephritis. Production of anti-dsDNA antibody and total IgG and IgG2a were significantly lower in TgH mice than those of TgL and WT mice. The expressed amounts of interferon (IFN){gamma} and IL4 mRNA by CD4+ T cells from Tg mice decreased in a dose-dependent fashion. CD4+ splenic lymphocytes in TgH mice were more subject to the IL27-mediated suppression of cytokine production. In vitro stimulation of CD4+ T cells by IL27 resulted in over phosphorylation of STAT3 in TgH cells than in WT cells.

Conclusion: WSX-1 overexpression in the MRL/lpr background rendered the autoimmune prone mice protected from the development of autoimmune diseases. Our results suggest that IL27 signalling may be a therapeutic target against autoimmune diseases, including human SLE.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs